New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
11:09 EDTHZNP, VJET, YOKU, CTRX, CBSOptions with increasing implied volatility: HZNP VJET YOKU CTRX CBS
News For HZNP;VJET;YOKU;CTRX;CBS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 16, 2014
09:57 EDTCBSCBS All Access not meant to be a disrupter to eco-system, says Wells Fargo
Subscribe for More Information
09:18 EDTCBSMoonves: Showtime standalone service in 'not too distant future,' NY Times says
Subscribe for More Information
09:09 EDTCBSCBS announces launch of stand-alone web subscription service
CBS announced the launch of CBS All Access, a new digital subscription video on demand and Nielsen-measured live streaming service for the CBS Television Network. CBS All Access will offer subscribers thousands of episodes from the current season, previous seasons and classic shows on demand, as well as the ability to stream local CBS Television stations live in 14 of the largest U.S. markets at launch. CBS All Access is available beginning today at CBS.com and on mobile devices through the CBS App for iOS and Android. CBS All Access will cost $5.99 per month.
06:03 EDTCBSStocks with implied volatility above IV index mean; AFSI CBS
Subscribe for More Information
October 15, 2014
06:15 EDTCBSCBS upgraded to Buy from Neutral at Citigroup
Citigroup upgraded its rating on CBS (CBS) to Buy citing a compelling risk/reward profile following the recent pullback in shares. Citi believes investor concerns over a softer advertising market and potential renegotiations of retransmission fees are warranted. The firm, however, sees upside from current share levels. It lowered its price target for CBS to $60 from $64. The stock closed yesterday up $1.02 to $49.93.
October 14, 2014
07:23 EDTCBSCBS more attractive than Disney, says Wells Fargo
Among media and cable stocks, Wells Fargo sees the least risk and most reward potential in CBS (CBS). The firm sees the least reward potential and most risk in Disney (DIS). The firm believes that the market is overestimating the ad declines for CBS, and it thinks that CBS' stock may have finally bottomed. Disney has a relatively expensive valuation and tough comps, added Wells Fargo, which keeps Outperform ratings on both stocks.
October 13, 2014
17:06 EDTHZNPHorizon Pharma: Actimmune net sales potential $500M with FDA approval for FA
Subscribe for More Information
09:06 EDTCBSNetflix, CBS sign distribution deal in Europe, Hollywood Reporter says
Subscribe for More Information
08:06 EDTYOKUQihoo 360 launches ad exchange platform, Marbridge Daily reports
Subscribe for More Information
07:39 EDTCTRXPharmaceutical Care Management Association to hold annual meeting
Subscribe for More Information
07:07 EDTCBSCBS sell-off brings 'interesting' entry point, says Piper Jaffray
Piper Jaffray says the recent pullback in shares of CBS provides an "interesting" entry point with the new broadcast season showing promise. Piper sees upside to 2015 consensus estimates and keeps an Overweight rating on CBS with a $75 price target.
05:31 EDTHZNPHorizon Pharma to host analyst day
Analyst Day to be held in King of Prussia, PA on October 13 at 5 pm. Webcast Link
October 10, 2014
13:17 EDTCBSNielsen to restate some TV rating due to software glitch, Variety reports
Nielsen (NLSN) acknowledged it uncovered a software error on October 6 that had resulted in TV ratings being allocated incorrectly among broadcast and syndication programming since March 2 and that it would restate the ratings accordingly to fix the errors, reported Variety. The company said 98% to 99% of ratings would not be affected by more than .05 of a ratings point and a person familiar with the situation said some TV networks have an expectation that some of their new fall programming will see a very slight uplift due to the restatement, the report noted. The big four broadcast networks are operated by CBS (CBS), Comcast (CMCSA), Disney (DIS) and 21st Century Fox (FOXA). Reference Link
October 9, 2014
15:31 EDTHZNPHorizon Pharma's Actimmune Phase 2 results provide more growth, says Avondale
Avondale said Horizon Pharma's Actimmune Phase 2 results were strong and support incremental annual market opportunity of approximately $300K per year. The firm views the results as another potential growth driver and its Outperform rating and $22 price target.
13:40 EDTHZNPHorizon Pharma presents ACTIMMUNE Phase 2 data
Subscribe for More Information
09:12 EDTCTRXCatamaran acquisition in-line with expectations, says Leerink
Subscribe for More Information
07:37 EDTCTRXCatamaran acquisition likely to be well-received, says Oppenheimer
Subscribe for More Information
October 8, 2014
16:34 EDTCTRXCatamaran to acquire Salveo Specialty Pharmacy for $260M in cash
Catamaran announced that it has entered into a definitive agreement to acquire Salveo Specialty Pharmacy, an independent specialty pharmacy company headquartered in St. Petersburg, Florida with business operations in New York and California. Salveo manages approximately $400M in annual drug spend. The purchase price of $260M in cash represents a purchase price multiple of approximately 13x Salveo's trailing-twelve-month EBITDA and is expected to be funded through cash on the balance sheet. This acquisition is expected to be completed during Q4.
06:04 EDTYOKUYouku Tudou appoints Teddy Gu as Chief Product Officer
Subscribe for More Information
October 7, 2014
08:05 EDTCBSCBS risk/reward attractive at current levels, says FBR Capital
FBR Capital believes weaker September quarter TV trends and downward estimate revisions have pushed CBS shares into "value territory." The firm views the current risk/reward on shares as attractive and keeps an Outperform rating on CBS with a reduced price target of $71.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use